Csenge Advisory Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,228
| Closed | -$222K | – | 733 |
|
|
2023
Q4 | $222K | Buy |
+2,228
| New | +$222K | 0.01% | 602 |
|
|
2023
Q2 | – | Sell |
-1,858
| Closed | -$285K | – | 682 |
|
|
2023
Q1 | $285K | Buy |
1,858
+681
| +58% | +$105K | 0.02% | 482 |
|
|
2022
Q4 | $211K | Buy |
+1,177
| New | +$211K | 0.02% | 551 |
|
|
2022
Q2 | – | Sell |
-1,305
| Closed | -$225K | – | 644 |
|
|
2022
Q1 | $225K | Buy |
1,305
+382
| +41% | +$65.9K | 0.02% | 572 |
|
|
2021
Q4 | $217K | Buy |
923
+103
| +13% | +$24.2K | 0.02% | 514 |
|
|
2021
Q3 | $280K | Sell |
820
-103
| -11% | -$35.2K | 0.02% | 487 |
|
|
2021
Q2 | $217K | Buy |
+923
| New | +$217K | 0.02% | 517 |
|